Barclays’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NUVB
JHC
Barclays's NUVB Position: Q3 2026 in Review
Barclays increased its Nuvation Bio (NUVB) stake by 187% in Q3 2026, buying an estimated $2.71M and bringing the position to 664,537 shares worth $3.72M. The position accounts for ﹤0.01% of the portfolio, ranked #2200.
Barclays first reported a position in NUVB in Q1 2022 and has held it in 19 quarters since. The position peaked at $5.84M in Q1 2024. 196 funds tracked by Wall St. Rank hold NUVB as of Q3 2026.
- Barclays held 664,537 shares of Nuvation Bio worth $3.72M as of Q3 2026.
- Barclays bought 432,743 Nuvation Bio shares in Q3 2026, an estimated $2.71M.
- Nuvation Bio made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #2200 holding.
- Barclays first reported a position in Nuvation Bio in Q1 2022 and has held it in 19 quarters since.
- Barclays's Nuvation Bio position peaked at $5.84M in Q1 2024.
- 196 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2026.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.